Eli Lilly and Company Limited

Lilly House, Priestley Road, Basingstoke, Hampshire, RG24 9NL
Telephone: +44 (0)1256 315 000
Fax: +44 (0)1256 775 858
WWW: http://www.lilly.co.uk
Medical Information e-mail: ukmedinfo@lilly.com
Medical Information Fax: +44 (0)1256 775 569

Patient Information Leaflet last updated on the eMC: 13/05/2011
PIL Humalog Mix50 100 U/ml suspension for injection in cartridge

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13/05/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to side-effects
Updated on 15/03/2011 and displayed until 13/05/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 21/09/2009 and displayed until 15/03/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to storage instructions
Updated on 13/06/2007 and displayed until 21/09/2009
Reasons for adding or updating:
  • Change to drug interactions
  • Change to date of revision
Updated on 31/07/2006 and displayed until 13/06/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 09/05/2006 and displayed until 31/07/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   insulin lispro